Stone Summit Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Stone Summit Wealth's BMY Position: Q3 2026 in Review
Stone Summit Wealth increased its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2026, buying an estimated $177K and bringing the position to 27,604 shares worth $1.72M. The position accounts for 0.47% of the portfolio, ranked #58.
Stone Summit Wealth first reported a position in BMY in Q1 2022 and has held it in 19 quarters since. 481 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Stone Summit Wealth held 27,604 shares of Bristol-Myers Squibb worth $1.72M as of Q3 2026.
- Stone Summit Wealth bought 2,796 Bristol-Myers Squibb shares in Q3 2026, an estimated $177K.
- Bristol-Myers Squibb made up 0.47% of Stone Summit Wealth's portfolio in Q3 2026, its #58 holding.
- Stone Summit Wealth first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 19 quarters since.
- 481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Stone Summit Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.